Home > Insider Trading > Theseus Pharmaceuticals Inc.

Theseus Pharmaceuticals Inc. (THRX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 40
Next >>

Micron Technology, Inc. (MU), Theravance Inc (THRX): Here's What Superinvestor Seth Klarman Has Been Buying

Today let's look at investing giant Seth Klarman, who founded the Baupost Group hedge fund company back in 1982. Klarman is a successful investor with a lot to teach us.

Keep Reading →

August 23rd, 2013 - Hedge Funds

SandRidge Energy Inc. (SD), Freeport-McMoRan Copper & Gold Inc. (FCX): Litespeed's Penchant For Distressed Assets Just Won't Quit

Jamie Zimmerman founded Litespeed Management, an event-driven hedge fund focusing on special situations, distressed securities, and bankruptcies, in 2000.

Keep Reading →

August 15th, 2013 - Hedge Funds

Theravance Inc (THRX), Novartis AG (ADR) (NVS): Respiratory Drug Maker About to Take Off

Chronic obstructive pulmonary disease (COPD) is America’s third leading cause of death. It is a lung disease caused due to continuous poor airflow as a result of which the lung tissues breakdown.

Keep Reading →

August 5th, 2013 - News

Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Which of These COPD Treatments Will Come Out on Top?

To most people, cigarettes are often associated with lung cancer. However, smoking also causes other severe respiratory problems, such as COPD (chronic obstructive pulmonary disease).

Keep Reading →

July 30th, 2013 - News

GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Pfizer Inc. (PFE): 3 Potential Game Changers for COPD

Over 13 million Americans have it. More than 120,000 of them die every year. Chronic obstructive pulmonary disease, or COPD, stands as the third leading cause of death in the U.S.

Keep Reading →

July 17th, 2013 - News

Is Elan Corporation, plc (ADR) (ELN) Pushing Its Luck?

Recently Elan Corporation, plc (ADR) (NYSE:ELN)'s shareholders voted against management's proposal to invest $1 billion in Theravance Inc (NASDAQ:THRX), a deal which a fellow Fool calculates to be ill...

Keep Reading →

June 18th, 2013 - News

Hedge Funds Are Betting On Theravance Inc (THRX)

In the eyes of most investors, hedge funds are seen as slow, old investment vehicles of yesteryear.

Keep Reading →

June 11th, 2013 - News

Hedge Funds Are Buying Incyte Corporation (INCY)

If you'd ask most investors, hedge funds are seen as underperforming, outdated financial tools of years past.

Keep Reading →

June 3rd, 2013 - News

GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc (THRX): This Week in Biotech

With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

May 20th, 2013 - News